Table 2.
Patient characteristics and medicine used.
| n | % | |
|---|---|---|
| Sex | ||
| Women | 33 | 34 |
| Men | 63 | 66 |
| Comorbid disease | ||
| No | 15 | 16 |
| Yes | 81 | 84 |
| Causes of bleeding | ||
| Erosive gastritis | 33 | 34 |
| Gastric ulcer | 28 | 29 |
| Duodenal ulcer | 22 | 23 |
| Duodenal+gastric ulcer | 8 | 8.5 |
| Other | 5 | 5.5 |
| Forrest classification of ulcers | ||
| Spurting hemorrhage | 2 | 3 |
| Oozing hemorrhage | 4 | 7 |
| Non-bleeding visible vessel | 4 | 7 |
| Adherent clot | 5 | 9 |
| Hematin covered lesion | 8 | 14 |
| Clean based | 35 | 60 |
| Medicine used | ||
| NSAID alone | 16 | 17 |
| NSAID plus ASA | 3 | 3.1 |
| NSAID plus clopidogrel | 2 | 2.1 |
| NSAID plus anticoagulant | 9 | 9.3 |
| ASA alone | 33 | 34 |
| ASA plus clopidogrel | 4 | 4.2 |
| ASA plus anticoagulant | 7 | 7.3 |
| Clopidogrel alone | 14 | 14.6 |
| Clopidogrel plus anticoagulant | 5 | 5.2 |
| Warfarin alone | 2 | 2.1 |
| Rivaroxaban alone | 1 | 1.1 |
| The division medicine prescribed in | ||
| Internal medicine | 7 | 7.2 |
| Physical therapy and rehabilitation | 3 | 3.1 |
| Cardiology | 44 | 46 |
| Neurology | 8 | 8.3 |
| Cardiovascular surgery | 8 | 8.3 |
| Chest diseases | 3 | 3.1 |
| General practitioner | 6 | 6 |
| Patients’ own use | 16 | 17 |
| Unknown | 1 | 1 |
| PPI use prior to bleeding | 20 | 21 |
| Helicobacter pylori positive* | 2 | 18 |
| Mortality | 1 | 1 |
NSAID: non-steroidal anti-inflammatory drug; ASA: aminosalicylic acid; LMWH: low molecular weight heparin; PPI: proton-pump inhibitor.
*
CLO test was performed in 11 of 96 patients and positive in 2 of 11 patients (%18).